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Introduction
Dementia is one of the most common neurological 
diseases and one of the most critical health-threatening 
factors in the elderly that has a devastating effect.1 
Alzheimer’s disease is one of the most prominent causes 
of dementia, with its prevalence increasing as the world’s 
aging population grows.2 Alzheimer’s disease is a brain-
related structural and functional disorder that gradually 
disrupts one’s mental abilities such as thinking, reasoning, 
judgment, and memory 3 and has symptoms such as 
memory problems, personality changes, depression, and 
anxiety. 4 In other words, Alzheimer’s disease recognized 
as a progressive amnestic disorder with associated 
neurological, cognitive, and behavioral deficits.5 In this 
disease, an abnormal accumulation of a protein called 
amyloid-beta occurs outside of the nerve cells, and 
Tao protein occurs inside the nerve cell. This protein 
accumulation inside and outside the nerve cell disrupts 
neuronal network communication and eventually 
destroys nerve cells.6,7 Atrophy of brain areas such as the 
hippocampus, amygdala, temporal lobe, and reduction 
of cortical thickness are other issues that have raised 
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Abstract
Background: Alzheimer’s disease is predicted to increase dramatically in the near future. Alzheimer’s 
caregiving brings about severe problems for caregivers. Considering the corrosive consequences of 
Alzheimer’s disease on Alzheimer’s caregivers, finding an effective intervention is necessary. Thus, 
the present research conducted by the aim of investigating the effectiveness of cognitive-behavioral 
treatment for Alzheimer’s disease patients and their caregiver’s protocol on burdens of Alzheimer’s 
disease on caregivers and their sense of coherence (SOC).
Methods: This study was a quasi-experimental research with a pretest-posttest control group design. 
The target population included all mild Alzheimer’s disease patients and their caregivers referred to the 
neurology ward of the hospitals in Rasht during summer 2018. According to the medical records and 
results of screening, 40 mild Alzheimer’s disease, patients and their caregivers recruited by convenience 
sampling method. After sampling, research participants randomly assigned into two experimental (n= 
20) and waitlist control (n = 20) groups. The Impact of Alzheimer’s Disease on Caregiver Questionnaire 
and SOC scale were used to measure the burdens of Alzheimer’s disease on caregivers and caregivers’ 
SOC. The CBTAC provided for the experimental group participants in 25 sessions of 90-minutes. In the 
end, the data analyze has done by multivariate analysis of covariance (MANCOVA) and using SPSS24 
software.
Results: The findings indicated that the CBTAC had a significant effect on the burdens and SOC of 
Alzheimer’s caregivers in the experimental group (P < 0.01). In other words, the CBTAC decreases 
burdens and increase the SOC of Alzheimer’s caregivers significantly (P < 0.01). 
Conclusion: Based on the research results, the CBTAC is an effective intervention in decreasing caregiving 
burden and the increasing SOC of Alzheimer’s caregivers. Therefore, CBTAC is a multicomponent 
intervention that can be used to improve the competency and mental health of Alzheimer’s caregivers.
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concerning Alzheimer’s disease.8
In general, the multiplicity and variety of personal, 
family, and social problems and consequences of 
Alzheimer’s disease complicate the care of patients. 
In addition to the harmful physical effects, the self-
destructive and gradual destruction of the patient’s mind 
creates a wide range of physical, emotional, psychological, 
social, and economic needs for the affected person, 
family, and caregiver. Indeed, it must acknowledge that 
caring for patients with Alzheimer’s goes far beyond a set 
of physically focused medical and nursing guidelines and 
is also a psychological and social phenomenon.9-11 Taking 
care of the elderly with Alzheimer’s disease is a daunting 
task, and caregivers of this group of elderly faced with 
many problems such as stress, anxiety, and depression 
for proper care of the patient.12 The caring of the elderly 
with Alzheimer’s disease, given the burden placed on 
caregivers, leads to psychological stress on caregivers.10 In 
other words, caring for this group of elderly affects the 
various dimensions of caregivers known as the concept of 
burdens of caregiver.10,13 In general, the burden of caring 
refers to the negative consequences of caring for chronic 
patients for their caregivers.14 Meanwhile, Alzheimer’s 
elderly are among the groups that can bring high levels 
of caregiver burden to their caregivers.15 Ferrara et al12 
report that stress, anxiety, and depression are common in 
Alzheimer’s caregivers. The results of the study conducted 
by Montgomery et al16 show that Alzheimer’s disease 
affects the mental health of patients and their caregivers. 
Sadik and Wilcock17 also emphasize the significant 
burden that Alzheimer’s places on caregivers and the 
health care system. Also, Rymer et al18 confirm that 
caregivers of Alzheimer’s patients experience a burden of 
caring. In another study, Pudelewicz et al10 point out the 
importance of caregiver burden and caregiver burnout. 
Cross-sectional and longitudinal results of the study 
conducted by Mohamed et al19 also show that the burden 
of care for Alzheimer’s disease is an important issue that 
can be affected by psychiatric symptoms, behavioral 
disturbances and quality of patient’s life. Moreover, the 
findings of studies by Brodaty et al20 and Etters et al21 
show that caring for dementia and Alzheimer’s patients 
is associated with adverse effects on caregivers’ health. 
Studies show that caregiving burden in Alzheimer’s 
disease is a critical issue that necessitates interventions 
to reduce the burden of caregivers’ care in this group of 
elderly.
In addition to the burden of care, a sense of cohesion 
is another important issue for caregivers of Alzheimer’s 
patients. Antonovsky22,23 put forward the concept of 
sense of coherence to explain the attitude of people to 
the stressors. Within the frame of the salutogenic model, 
Antonovsky introduced generalized resistance resources 
(GRR), in which repeated use of GRR leads to a sense of 
coherence (SOC). GRR, and SOC interrelated. The sense of 
coherence refers to a general tendency that sees the world 
and the environment of personal life as understandable, 
manageable, and meaningful, claiming that the way 
people view their lives has a positive impact on their 
health.22,23 The SOC is a health‐promoting resource that 
is related to the different aspects of health.24 Studies have 
shown the important role of the SOC in Alzheimer’s care. 
Andrén and Elmståhl25 suggest that there is a relationship 
between the burden of care, perceived health, and the 
SOC of caregivers of dementia and Alzheimer’s patients. 
Pretorius et al,26 Potgieter and Heyns,27 and Elnasseh et 
al28 also confirm the relationship between Alzheimer’s 
care and a SOC. Furthermore, Välimäki et al29 examined 
the SOC in caregivers of Alzheimer’s patients in the 
three-year follow-up. The results suggest a decrease 
in caregivers’ SOC. Childers30 confirms the role of the 
SOC in health, health-related quality of life, and stress 
of Alzheimer’s caregivers. Accordingly, the SOC is a very 
prominent component to consider Alzheimer’s caregiver.
Alzheimer’s disease is predicted to increase dramatically 
in the future,31 given the association of Alzheimer with 
anxiety,32 depression,33 personality disorders,34 sleep 
disorders,35 physical and functional health problems36 
as well as negative family,37 social and economic 
consequences38,39 of Alzheimer’s disease, it is essential 
to find interventions related to Alzheimer’s disease. 
In the meantime, psychological programs are among 
the interventions that have been proposed concerning 
Alzheimer and have considered in recent years.40
One of the psychological interventions for mild 
Alzheimer’s disease is the cognitive-behavioral treatment 
for Alzheimer’s disease patients and their caregivers.41 
CBTAC is an intervention that incorporates specific 
cognitive (e.g., cognitive reconstructing) and behavioral 
(e.g., behavioral management) components and generally 
based on cognitive-behavioral theory.42 CBTAC consists 
of diagnosis and goal setting, psycho-education, 
engagement in pleasant activities, cognitive restructuring, 
life review, behavioral management techniques, and 
couples counseling and targets caregivers in addition 
to Alzheimer’s patients.41 CBTAC can be an effective 
method of incorporating a wide range of cognitive and 
behavioral elements in both Alzheimer’s patients and 
their caregivers, which can affect the burden of care and 
the SOC of caregivers of Alzheimer’s patients. 
Overall, effective psychological interventions are 
necessary for the view of the widespread Alzheimer’s 
disease and its wide-ranging negative consequences 
for patients and their caregivers at the individual, 
interpersonal, and collective levels. In the meantime, 
CBATC can be an effective intervention in the burden 
of care and a SOC for caregivers of Alzheimer’s patients, 
with emphasis on the cognitive and behavioral elements 
of both patients and caregivers. In this regard, the purpose 
of the present study is to examine the effectiveness of 
CBTAC protocol on the burdens of Alzheimer’s disease 
on caregivers and their SOC.
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Methods
This study was a quasi-experimental research with a 
pretest-posttest control group design. The main purpose 
of the study was to investigate the effectiveness of CBTAC 
protocol on the burdens of Alzheimer’s disease on 
caregivers and their SOC. The target population included 
all mild Alzheimer’s disease patients and their caregivers 
referred to the neurology ward of the hospitals in first and 
second districts of Rasht during summer 2018. According 
to the medical records and results of screening, 40 mild 
Alzheimer’s disease, patients and their caregivers recruited 
by convenience sampling method. Inclusion criteria for 
Alzheimer’s disease patients included diagnosis of mild 
Alzheimer’s disease, absence of uncontrolled severe 
physical and psychological disorders, and not receiving 
other psychological interventions. In the case of caregivers 
of Alzheimer’s disease patients, inclusion criteria 
consisted of caring mild Alzheimer’s disease patients, 
lack of serious physical and psychological problems, 
and not receiving specific physical and psychological 
interventions. The criteria for exclusion include absence 
in more than two sessions, causing problems in the 
intervention process, reluctance to cooperate in the 
treatment sessions, and lack of personal satisfaction. 
Written informed consent obtained from each participant. 
After sampling, research participants (Alzheimer’s 
patients and their caregivers) randomly assigned into 
two experimental (n = 20) and waitlist control (n = 20) 
groups. The Impact of Alzheimer’s Disease on Caregiver 
Questionnaire (IADCQ)13 and SOC scale43 were used to 
measure the burdens of Alzheimer’s disease on caregivers 
and caregivers’ SOC. Before the intervention, caregivers 
responded to study measurements, then the participants 
(both patients and caregivers) in the experimental group 
underwent the cognitive-behavioral treatment for mild 
Alzheimer’s patients and their caregivers41 in 25 sessions 
of 90-minutes (2 sessions per week). The content of 
CBTAC sessions has been presented in Table 1 summarily. 
After the intervention, a post-test executed on both the 
experimental group and the waitlist control group. Data 
analysis have done by multivariate analysis of covariance 
(MANCOVA) and using SPSS version 24 software At 
the end of the study, Due to ethical considerations, the 
intervention also offered to the waitlist control group. 
The Impact of Alzheimer’s Disease on Caregiver 
Questionnaire
The IADCQ is developed to measure the level of burden of 
Alzheimer’s disease on caregivers. The IADCQ composed 
of 12 items that measure Alzheimer’s disease caregiver’s 
burden across emotional, physical, social, financial, sleep, 
and time aspects. The response and rating format for the 
IADCQ is a 5-point scale with anchor points being not at 
all equal to 0, and extremely equal to 4. The participant’s 
score is between 0-48. Cole et al13 reported adequate 
reliability and validity of the questionnaire. The IADCQ 
had a mean scale score of 21.6 and a standard deviation of 
10.8. Findings showed that the IADCQ is unidimensional 
and covers an ideal range of burdens. In Cole et al’s 
study,13 internal consistency with a coefficient alpha 
Table 1. The Summary of the CBTAC Protocol
Topics Session Content Setting
Diagnosis and goal setting
Diagnostic investigation Joint
Behavior analysis and goal setting Joint
Psychoeducation Psychoeducation Joint
Engagement in pleasant activities
Setting the stage for pleasant activities Joint
Planning of pleasant activities Possibly without caregiver
Establishing regular activities Joint
Cognitive restructuring
Setting the stage for cognitive restructuring Joint
Challenging negative thoughts Possibly without caregiver




Young adulthood Without caregiver
Older adulthood Without caregiver
Training caregiver in behavior management 
techniques
Setting the stage for behavior management Joint
Changing problem behavior Joint - Possibly without the caregiver
Interventions for the caregiver
Stress management and emotion regulation Only caregiver
Pleasant activities Only caregiver
Social support Only caregiver
Couples counseling
Setting the stage for couples counseling Joint
Communication and joint problem-solving training Joint
Acceptance and planning for the future Joint
Closing of therapy Summary and reflection Joint
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and an intra-class correlation coefficient were 0.93 and 
0.68, respectively. Additionally, correlations between the 
IADCQ and the SF-12v2, PCS, and MCS scales indicate 
the appropriate validity of the IADCQ. In the present 
study, the IADCQ was internally consistent, as well (α= 
0.87).
The Sense of Coherence Scale
The SOC Scale is a 29-items and single-factor instrument 
for measuring the SOC. The purpose of the SOC is 
to measure the comprehensibility, manageability, and 
meaningfulness. The SOC has a 7-point Likert scale with 
response choices ranging from 1 to 7. Thirteen of the 
items have reversed in scoring. The questionnaire yields a 
summed score with a range from 29 to 203. Higher scores 
express a higher level of SOC. According to Antonovsky’s 
study43, the SOC has appropriate psychometric properties. 
The SOC had a different mean score (117.0 to 152.6) and a 
standard deviation (0.8 to 36.4). In 26 studies using SOC-
29, the Cronbach alpha measure of internal consistency 
has ranged from 0.82 to 0.95.
Furthermore, the test-retest reliability of the SOC 
was satisfactory. The correlations between the SOC 
and measures of global orientation to oneself and one’s 
environment, health, illness and wellbeing, stressors, 
and attitudes confirmed the appropriate validity of the 
scale. The systematic review of Eriksson and Lindström44 
indicates that the SOC is a reliable, valid, and cross-
culturally applicable instrument. Alipour and Sharif45 also 
confirmed the excellent psychometric properties of the 
SOC in Iran. In the present research, the alpha reliability 
was 0.88.
Results
The mean and standard deviation of the burdens of 
Alzheimer’s disease and the SOC pre-test-post-test scores 
in the experimental and control groups presented in Table 
2. In this table, the results of the Kolmogorov–Smirnov 
test reported in order to verify the normal distribution 
of variables in two groups. According to this table, the 
Z-statistic of the Kolmogorov–Smirnov test was not 
significant for all variables. Therefore, it can conclude that 
the distribution of variables is normal.
For investigating the effectiveness of CBTAC protocol 
on burdens of Alzheimer’s disease on caregivers and their 
SOC, MANCOVA was used.
The results of Levene’s test for investigating the 
homogeneity of dependent variables variance in groups 
showed that the variance of burdens of Alzheimer’s 
disease (F1.38 = 0.43, P = 0.513 ) and SOC (F1.38 = 2.70, P 
= 0.108 > 0.05 )is equal in groups. The results of the M 
Box test for checking the equality of the covariance matrix 
of dependent variables between the experimental and 
control groups also showed that the covariance matrix 
of dependent variables of two groups was equal (M 
Box= 4.757, F = 1.49, P = 0.214 > 0.05). The significance 
level of the Box test is more significant than 0.05, and 
this assumption established. The results of chi-square 
and Bartlett’s tests for sphericity or significance of the 
relationship between burdens of Alzheimer’s disease and 
SOC showed that the relationship between them was 
significant (P < 0.05, χ2 = 33.94, df = 2). Another critical 
assumption of multivariate analysis of covariance is the 
homogeneity of regression coefficients.
It should be noted that the test of homogeneity of 
regression coefficients investigated through the interaction 
of dependent and independent variables (intervention 
method) in pre-test and post-test. The interaction of these 
pre-tests and post-tests with the independent variable 
was not significant and indicated the homogeneity of the 
regression slope, so this assumption established. Due to 
the assumptions of multivariate analysis of covariance, 
the use of this test will have permitted. Multivariate 
analysis of covariance performed in order to find out the 
differences between groups (Table 3).
According to Table 3, the results showed the effect of 
the independent variable on the dependent variables; in 
other words, the experimental and control groups had 
significant difference at least in one of the variables of 
burdens of Alzheimer’s disease and SOC, that 56% of total 
variances of the experimental and control groups were 
due to the independent variable regarding the calculated 
effect size. The statistical power of the test is also equal to 
one, indicating the adequacy of the sample size. However, 
in order to determine which domains are significant, 
the univariate analysis of covariance was used in the 
Table 2. Descriptive Indices of Study’s Variables in Wait List Control and Experimental Groups
Variables Groups Mean SD K-S Z P
Burdens of Alzheimer’s 
disease
Pre-test
Wait List Control Group 21.05 8.24 0.137 0.055
Experimental Group 21.55 8.73 0.123 0.063
Post-test
Wait List Control Group 21.20 3.62 0.124 0.125
Experimental Group 17.15 3.42 0.103 0.161
SOC
Pre-test
Wait List Control Group 120.45 11.54 0.123 0.128
Experimental Group 120.05 15.22 0.108 0.081
Post-test
Wait List Control Group 120.10 7.44 0.124 0.124
Experimental Group 129.55 12.34 0.105 0.094
SOC, sense of coherence; K-S Z: Z-statistic of the Kolmogorov–Smirnov. 
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MANCOVA. The results of which reported in Table 4.
According to Table 4, F statistic for burdens of 
Alzheimer’s disease (12.88) and SOC (8.09) was 
significant at 0.01 levels. These findings indicate that 
there is a significant difference between groups in these 
variables. Also, according to the calculated effect size, 
26% of Burdens of Alzheimer’s Disease and 18% of the 
SOC were due to the effect of the independent variable. 
Accordingly, it can note that the CBTAC protocol was 
active on the burdens of Alzheimer’s disease on caregivers 
and their SOC. 
Discussion
The present study aimed to study the effectiveness of the 
CBTAC protocol on the burdens of Alzheimer’s disease 
on caregivers and their SOC. Based on the findings, 
CBTAC was valid on Burdens and the SOC of Alzheimer’s 
caregivers. The results indicated that the CBTAC was 
effective and reduced the caregiving burden and increased 
the sense of cohesion of Alzheimer’s caregivers.
Alzheimer’s disease has many negative consequences for 
Alzheimer’s patients and their caregivers as a progressive 
amnestic disorder,5 which leads to problems in the care 
of Alzheimer’s patients.9-11 Burdens of caregiver and a 
SOC are among the most critical issues to consider in 
caring for Alzheimer’s patients. Alzheimer’s disease puts 
stress on caregivers10 and leads to stress, anxiety, and 
depression in caregivers.12 In line with this, the results of 
the studies of Ferrara et al,12 Montgomery et al,16 Sadik & 
Wilcock,17 Rymer et al,18 Pudelewicz et al,10 Mohamed et 
al,19 Brodaty et al,20 Etters et al21 emphasize the burden of 
Alzheimer’s disease care. Also, the SOC is another critical 
issue in the care of Alzheimer’s patients. According to 
the results of studies by Andrén & Elmståhl,25 Pretorius 
et al,26 Potgieter and Heyns,27 Elnasseh et al,28 Välimäki 
et al29 and Childers,30 SOC is a prominent factor in the 
care of Alzheimer’s disease. It should acknowledge that 
the burden of care and the SOC of Alzheimer’s caregivers 
are critical issues that require interventions to reduce 
the burden of care and increase the SOC in caregivers. 
In the meantime, CBTAC can affect the burden of care 
Table 3. The Results of Multivariate Analysis of Covariance on Mean Post-
Test Scores
Test Value F P Effect Value
Pillai's effect 0.365 10.05 0.001 0.365
Wilks Lambda 0.635 10.05 0.001 0.365
Hotelling trace 0.575 10.05 0.001 0.365
Roy's largest root 0.575 10.05 0.001 0.365
Table 4. Results of Univariate Analysis of Covariance on the Mean of Post-test Scores of Dependent Variables in 2 Experimental and Control Groups
Variables SS df MS F P Effect Value
Burdens of Alzheimer’s disease 165.430 1 165.430 12.88 0.001 0.264
SOC 876.464 1 876.464 8.09 0.007 0.184
and a SOC for patient caregivers as a cognitive-behavioral 
intervention while encompassing a wide range of cognitive 
and behavioral elements in both Alzheimer’s patients and 
their caregivers. The results of this study are in line with 
the findings of the study conducted by Frostmeyer et al,41 
confirming the positive impact of CBTAC protocol on 
caregivers of Alzheimer’s patients.
In explaining this, it should acknowledge that 
CBTAC positively affects both Alzheimer’s patients 
and caregivers of Alzheimer’s patients, with emphasis 
on psychoeducation, pleasant activities, cognitive 
restructuring, life review, behavior management, and 
couples counseling. CBTAC gives information about 
Alzheimer’s disease and its stages, causes, treatments, 
and consequences for both patients and caregivers. This 
intervention also addresses engagement in pleasant 
activities and life review. CBTAC also leads to schema-
changing, cognitive reframing, challenging dysfunctional 
thoughts, finding alternative thoughts, increasing 
thought control through cognitive restructuring. This 
intervention also has positive behavioral consequences 
concerning behavioral management and behavioral 
reactions. CBTAC protocol positively affects the burden 
of care and the SOC of Alzheimer’s caregivers by making 
several cognitive and behavioral changes, an effect that is 
justified by cognitive-behavioral theories.42
Overall, the findings of the present study confirm the 
application of CBTAC in reducing the burden of care and 
increasing the SOC of caregivers of Alzheimer’s patients. 
Finally, it is necessary to state that the present study had 
some limitations. The limitations of the present study are 
lack of control over things such as caregivers’ education, 
their necessary information about Alzheimer’s disease, 
caregiver competence, closeness, and intimacy rate of 
caregiver with the patient.
For this reason, it is recommended that future studies 
be more controlled to clarify the impact of CBTAC 
on caregivers. Lack of attention to the gender of 
caregivers was one of the limitations. In this regard, it is 
recommended to consider in future studies whether the 
gender of caregivers is useful in the extent to which they 
are affected by the CBTAC protocol. Another limitation 
was the impossibility of the follow-up of the experiment 
after the study completed.
Conclusion
Based on the research results, the CBTAC is an effective 
intervention in decreasing caregiving burden and 
increasing the SOC of Alzheimer’s caregivers. Therefore, 
CBTAC is a multicomponent intervention that can be 
Shabahang et al
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used to improve the competency and mental health of 
Alzheimer’s caregivers.
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